Background on Creative PEGWorks website - leading PEG supplier.

Marketed PEGylated Drugs Approved by FDA and in Europe

An excellent review article is published by scientists from Nektar Therapeutics, Bayer, Jansen, and Baxalta Innovations GmbH in the journal of Journal of Pharmaceutical Sciences.

Journal of Pharmaceutical Sciences 105 (2016) 460-475
  
Since 1990, 12 PEGylated biopharmaceuticals have been introduced into the market place as drugs for human use (Table 1).Eleven are PEGylated protein biopharmaceuticals and one is aPEGylated aptamer (Macugen) administered intravitreally. Adagen®, Krystexxa®,
Neulasta®, Oncaspar®, PEG-Intron®, Somavert®, and Plegridy® are PEGylated with PEG molecules having molecular weight of 5-20kDa. Cimzia®, Macugen®, Mircera®, Omontys®, and Pegasys®are PEGylated with PEG molecules of 30 or 40 kDa.
  
  
  
Marketed PEGylated Drugs
Pin

Related Posts

  • FDA-Approved PEGylated Drugs

    To date, only eleven PEGylated proteins, antibody fragments, oligonucleotides, and small molecules that have been…

  • FDA-Approved PEGylated Drugs

    To date, only eleven PEGylated proteins, antibody fragments, oligonucleotides, and small molecules that have been…

  • FDA-Approved PEGylated Drugs

    To date, only eleven PEGylated proteins, antibody fragments, oligonucleotides, and small molecules that have been…